Chengjian Ji

机构：Nanjing University of Chinese Medicine, Nanjing Medical University · ORCID：0000-0001-9110-104X

发表论文 53 篇 · 总被引 557 次 · h-index 16

代表论文

• The circSPON2/miR-331-3p axis regulates PRMT5, an epigenetic regulator of CAMK2N1 transcription and prostate cancer progression (2022 · Molecular Cancer · 被引 49)
• Potential of testis-derived circular RNAs in seminal plasma to predict the outcome of microdissection testicular sperm extraction in patients with idiopathic non-obstructive azoospermia (2021 · Human Reproduction · 被引 29)
• A modified biodegradable mesh ureteral stent for treating ureteral stricture disease (2022 · Acta Biomaterialia · 被引 25)
• Identification of endocrine-disrupting chemicals targeting the genes and pathways of genital anomalies in males (2022 · Ecotoxicology and Environmental Safety · 被引 20)
• OGT/HIF-2α axis promotes the progression of clear cell renal cell carcinoma and regulates its sensitivity to ferroptosis (2023 · iScience · 被引 18)
• PYCR1 regulates glutamine metabolism to construct an immunosuppressive microenvironment for the progression of clear cell renal cell carcinoma. (2022 · PubMed · 被引 18)